Differences in Glycemic Control in Diabetic and Non-diabetic Patients with Parenteral Nutrition Using a Basal plus Correction Insulin Regimen: An Observational, Retrospective Study
Por:
Ramos, A, Rabasa, F, Mendoza, L, Cardenete, J, Gill, P, Morilla, A, Cardona, D, Perez, A
Publicada:
1 jun 2018
Resumen:
Introduction: Hyperglycemia is a frequent complication of parenteral nutrition (PN) in patients both with and without diabetes mellitis (DM). The aim of this study was to evaluate the quality of glucose control achieved with basal plus-correction insulin in surgical patients with and without a history of DM receiving PN.
Methods: Retrospective evaluation of a protocol applied during the period of January 2013-December 2015. The insulin dose was started at 0.4 and 0.3 IU/kg/day in patients with previous DM and without a history of DM, respectively, and the target blood glucose (BG) was < 180 mg/dl. Mean BG levels, insulin total daily dose (TDD) and hypoglycemic (< 70 mg/dl) events on different days of PN were also evaluated.
Results: Forty-one patients with previous type 2 DM and 39 without DM were evaluated. Glycemic control in both groups was as follows: during the first 48 h (230.4 +/- 67 vs. 189.4 +/- 38 mg/dl, p = 0.002); at the midpoint (224.6 +/- 58 vs. 181.3 +/- 27 mg/dl, p = 0.003); 48 h before ending TPN (196.4 +/- 43 vs. 169.8 +/- 40 mg/dl, p = 0.004). Insulin TDD was 0.5 +/- 0.3 U/kg/day in patients with DM and 0.37 +/- 0.3 units/kg/day in those without DM (p < 0.05). A total of 18 patients experienced hypoglycemic events, without differences between the groups.
Conclusion: A basal-correction insulin regimen is an alternative method for managing hyperglycemia in non-critically ill surgical patients on PN.
Filiaciones:
Ramos, A:
Hosp Santa Creu & Sant Pau, Dept Endocrinol & Nutr, Barcelona, Barcelona, Spain
Rabasa, F:
Hosp Santa Creu & Sant Pau, Dept Endocrinol & Nutr, Barcelona, Barcelona, Spain
Mendoza, L:
Hosp Santa Creu & Sant Pau, Dept Endocrinol & Nutr, Barcelona, Barcelona, Spain
Cardenete, J:
Hosp Santa Creu & Sant Pau, Dept Pharm Serv, Barcelona, Spain
Gill, P:
Hosp Santa Creu & Sant Pau, Dept Endocrinol & Nutr, Barcelona, Barcelona, Spain
Morilla, A:
Hosp Santa Creu & Sant Pau, Dept Endocrinol & Nutr, Barcelona, Barcelona, Spain
Cardona, D:
Hosp Santa Creu & Sant Pau, Dept Pharm Serv, Barcelona, Spain
Perez, A:
Hosp Santa Creu & Sant Pau, Dept Endocrinol & Nutr, Barcelona, Barcelona, Spain
Univ Autonoma Barcelona, Dept Med, Bellaterra, Spain
CIBER Diabet & Enfermedades Metab Asociadas CIBER, Madrid, Spain
Gold, Green Published
|